Acadia Healthcare Company, Inc.
ACHCNASDAQHealthcare● Active
$25.18
+$0.70(+2.85%)
Market Cap$2.3B
P/E Ratio—
52W High$30.2
52W Low$11.43
Acadia Healthcare Company, Inc. (ACHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ACHC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$0.37
Est. $0.28 · +32.1%
Revenue
$0.83B
Est. $0.82B · +0.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▲ Beat EPS🔥 5-Quarter EPS Beat Streak
ACHC reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.33 | — | — | — | $0.84B | — |
| ▲ Q2 FY2026 | Apr 29, 2026 | $0.28 | $0.37 | +32.1% | $0.83B | $0.82B | +0.6% |
| ▲ Q1 FY2026 | Feb 25, 2026 | $0.03 | $0.07 | +133.3% | $0.82B | $0.80B | +2.7% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.68 | $0.72 | +5.9% | $0.85B | $0.85B | +0.4% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.71 | $0.83 | +16.9% | $0.87B | $0.88B | -0.7% |
| ▲ Q2 FY2025 | May 12, 2025 | $0.35 | $0.40 | +14.3% | $0.77B | $0.77B | +0.1% |
| ▼ Q1 FY2025 | Feb 27, 2025 | $0.75 | $0.64 | -14.7% | $0.77B | $0.78B | -0.6% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.90 | $0.91 | +1.1% | $0.82B | $0.78B | +4.6% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.33
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Beat
EPS Actual
$0.37
EPS Est.
$0.28
EPS Surpr.
+32.1%
Revenue
$0.83B
Q1 FY2026
Feb 25, 2026Beat
EPS Actual
$0.07
EPS Est.
$0.03
EPS Surpr.
+133.3%
Revenue
$0.82B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$0.72
EPS Est.
$0.68
EPS Surpr.
+5.9%
Revenue
$0.85B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.83
EPS Est.
$0.71
EPS Surpr.
+16.9%
Revenue
$0.87B
Q2 FY2025
May 12, 2025Beat
EPS Actual
$0.40
EPS Est.
$0.35
EPS Surpr.
+14.3%
Revenue
$0.77B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
$0.64
EPS Est.
$0.75
EPS Surpr.
-14.7%
Revenue
$0.77B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.91
EPS Est.
$0.90
EPS Surpr.
+1.1%
Revenue
$0.82B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.42 | $0.42 | $0.43 | 7 |
| Q3 FY2028 | $0.67 | $0.68 | $0.70 | 4 |
| Q2 FY2028 | $0.58 | $0.59 | $0.61 | 6 |
| Q1 FY2028 | $0.41 | $0.42 | $0.43 | 4 |
| Q4 FY2027 | $0.34 | $0.34 | $0.35 | 6 |
| Q3 FY2027 | $0.55 | $0.56 | $0.57 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.9B | $1.0B | $1.0B | 6 |
| Q3 FY2028 | $1.0B | $1.0B | $1.0B | 3 |
| Q2 FY2028 | $0.9B | $0.9B | $1.0B | 5 |
| Q1 FY2028 | $0.9B | $0.9B | $0.9B | 3 |
| Q4 FY2027 | $0.9B | $0.9B | $0.9B | 7 |
| Q3 FY2027 | $0.9B | $0.9B | $0.9B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +32.1% | $27.58 | $28.26 | +2.47% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +133.3% | $17.17 | $20.84 | +21.37% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +5.9% | $20.66 | $20.68 | +0.10% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +16.9% | $21.37 | $21.76 | +1.82% |
| ▲ Q2 FY2025 | May 12, 2025 | +14.3% | $23.84 | $25.84 | +8.39% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -14.7% | $41.00 | $40.26 | -1.80% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +1.1% | $51.60 | $52.08 | +0.93% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +4.6% | $67.38 | $64.85 | -3.75% |
Q2 FY2026+2.47%
Report Date
Apr 29, 2026
EPS Beat/Miss
+32.1%
Price Before
$27.58
Price After
$28.26
Q1 FY2026+21.37%
Report Date
Feb 25, 2026
EPS Beat/Miss
+133.3%
Price Before
$17.17
Price After
$20.84
Q4 FY2025+0.10%
Report Date
Nov 5, 2025
EPS Beat/Miss
+5.9%
Price Before
$20.66
Price After
$20.68
Q3 FY2025+1.82%
Report Date
Aug 5, 2025
EPS Beat/Miss
+16.9%
Price Before
$21.37
Price After
$21.76
Q2 FY2025+8.39%
Report Date
May 12, 2025
EPS Beat/Miss
+14.3%
Price Before
$23.84
Price After
$25.84
Q1 FY2025-1.80%
Report Date
Feb 27, 2025
EPS Beat/Miss
-14.7%
Price Before
$41.00
Price After
$40.26
Q4 FY2024+0.93%
Report Date
Oct 30, 2024
EPS Beat/Miss
+1.1%
Price Before
$51.60
Price After
$52.08
Q3 FY2024-3.75%
Report Date
Jul 31, 2024
EPS Beat/Miss
+4.6%
Price Before
$67.38
Price After
$64.85
Avg Beat Reaction+4.48%
Avg Miss Reaction-1.80%
Beat Rate7 / 8 quarters
Largest Move+21.37% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ACHC ends December
Acadia Healthcare Company, Inc. (ACHC) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $0.37 — beating the analyst consensus of $0.28 by +32.1%. ACHC has beaten EPS estimates for 5 consecutive quarters. The next ACHC earnings date is expected around September 1, 2026.
Each quarter, investors track ACHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ACHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ACHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ACHC earnings · 5 questionsAcadia Healthcare Company, Inc.'s next earnings report is expected around September 1, 2026. ACHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ACHC historically reports after market close (AMC).
ACHC earnings datewhen is ACHC earningsACHC next earnings datewhen does ACHC report earningsACHC earnings calendar
▸ Source: FMP · Acadia Healthcare Company, Inc. SEC filings · US GAAP · Acadia Healthcare Company, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026